Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)

Sarcosine (N-methylglycine), a glutamatergic modulator, reduces the primary negative symptoms of schizophrenia. These beneficial changes might be mediated by trophic factors such as epidermal growth factor (EGF). We assessed associations between initial serum EGF levels or changes in serum EGF level...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlak, Agnieszka, Kaczmarek, Bartosz, Wysokiński, Adam, Strzelecki, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674361/
https://www.ncbi.nlm.nih.gov/pubmed/38004423
http://dx.doi.org/10.3390/ph16111557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674361/
https://www.ncbi.nlm.nih.gov/pubmed/38004423
http://dx.doi.org/10.3390/ph16111557

Ejemplares similares